Whittier Trust Co. of Nevada Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 55.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 20,435 shares of the healthcare conglomerate's stock after selling 25,222 shares during the period. Whittier Trust Co. of Nevada Inc.'s holdings in UnitedHealth Group were worth $6,375,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Lafayette Investments Inc. increased its stake in shares of UnitedHealth Group by 27.0% in the 2nd quarter. Lafayette Investments Inc. now owns 918 shares of the healthcare conglomerate's stock worth $286,000 after purchasing an additional 195 shares in the last quarter. Syntegra Private Wealth Group LLC increased its stake in shares of UnitedHealth Group by 8.0% in the 2nd quarter. Syntegra Private Wealth Group LLC now owns 1,711 shares of the healthcare conglomerate's stock worth $534,000 after purchasing an additional 127 shares in the last quarter. Liberty One Investment Management LLC increased its stake in shares of UnitedHealth Group by 46.0% in the 2nd quarter. Liberty One Investment Management LLC now owns 82,001 shares of the healthcare conglomerate's stock worth $25,582,000 after purchasing an additional 25,846 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in shares of UnitedHealth Group by 1.1% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 936,422 shares of the healthcare conglomerate's stock worth $291,636,000 after purchasing an additional 10,633 shares in the last quarter. Finally, Princeton Global Asset Management LLC boosted its holdings in UnitedHealth Group by 96.7% in the 2nd quarter. Princeton Global Asset Management LLC now owns 474 shares of the healthcare conglomerate's stock worth $148,000 after buying an additional 233 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Up 0.3%
Shares of NYSE:UNH opened at $365.47 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a 50-day moving average price of $333.70 and a 200 day moving average price of $341.28. The company has a market cap of $331.00 billion, a price-to-earnings ratio of 15.83, a PEG ratio of 2.36 and a beta of 0.47.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. The firm's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on UNH shares. KeyCorp upped their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an "overweight" rating in a report on Wednesday, October 8th. Robert W. Baird reaffirmed an "underperform" rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Barclays upped their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Finally, Weiss Ratings reissued a "sell (d+)" rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Hold" and an average target price of $385.13.
Get Our Latest Stock Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.